The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Seth Kiernan since 2022.
This trader's CIK number is 1890439.
At the time of last reporting, Seth Kiernan was the VP, Chief Commercial Officer of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | LXRX | 0 | $0 | 0 | $0 | 43,082 | $0 |
| 2022 | LXRX | 0 | $0 | 0 | $0 | 30,128 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-28 | LXRX | Option Ex | 43,082 | .00 | 0 |
| 2022-02-28 | LXRX | Option Ex | 30,128 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Seth Kiernan (VP, Chief Commercial Officer of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.